395 related articles for article (PubMed ID: 10683372)
1. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.
McHugh KP; Hodivala-Dilke K; Zheng MH; Namba N; Lam J; Novack D; Feng X; Ross FP; Hynes RO; Teitelbaum SL
J Clin Invest; 2000 Feb; 105(4):433-40. PubMed ID: 10683372
[TBL] [Abstract][Full Text] [Related]
2. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
3. A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.
Feng X; Novack DV; Faccio R; Ory DS; Aya K; Boyer MI; McHugh KP; Ross FP; Teitelbaum SL
J Clin Invest; 2001 May; 107(9):1137-44. PubMed ID: 11342577
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state.
Lane NE; Yao W; Nakamura MC; Humphrey MB; Kimmel D; Huang X; Sheppard D; Ross FP; Teitelbaum SL
J Bone Miner Res; 2005 Jan; 20(1):58-66. PubMed ID: 15619670
[TBL] [Abstract][Full Text] [Related]
5. Integrin subunit beta3 plays a crucial role in the movement of osteoclasts from the periosteum to the bone surface.
Holt I; Marshall MJ
J Cell Physiol; 1998 Apr; 175(1):1-9. PubMed ID: 9491775
[TBL] [Abstract][Full Text] [Related]
6. Alpha9beta1: a novel osteoclast integrin that regulates osteoclast formation and function.
Rao H; Lu G; Kajiya H; Garcia-Palacios V; Kurihara N; Anderson J; Patrene K; Sheppard D; Blair HC; Windle JJ; Choi SJ; Roodman GD
J Bone Miner Res; 2006 Oct; 21(10):1657-65. PubMed ID: 16995821
[TBL] [Abstract][Full Text] [Related]
7. Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF.
Stemig M; Astelford K; Emery A; Cho JJ; Allen B; Huang TH; Gopalakrishnan R; Mansky KC; Jensen ED
PLoS One; 2015; 10(4):e0123843. PubMed ID: 25875108
[TBL] [Abstract][Full Text] [Related]
8. Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis.
Zou W; Teitelbaum SL
J Cell Biol; 2015 Jan; 208(1):125-36. PubMed ID: 25547154
[TBL] [Abstract][Full Text] [Related]
9. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM
Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
[TBL] [Abstract][Full Text] [Related]
10. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin.
Faccio R; Novack DV; Zallone A; Ross FP; Teitelbaum SL
J Cell Biol; 2003 Aug; 162(3):499-509. PubMed ID: 12900398
[TBL] [Abstract][Full Text] [Related]
12. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
13. Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal.
Zhao H; Ross FP; Teitelbaum SL
Mol Endocrinol; 2005 Mar; 19(3):771-80. PubMed ID: 15591537
[TBL] [Abstract][Full Text] [Related]
14. Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia/ia) rats: implications for secretory function.
Reinholt FP; Hultenby K; Heinegård D; Marks SC; Norgård M; Anderson G
Exp Cell Res; 1999 Sep; 251(2):477-91. PubMed ID: 10471332
[TBL] [Abstract][Full Text] [Related]
15. c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation.
Faccio R; Takeshita S; Zallone A; Ross FP; Teitelbaum SL
J Clin Invest; 2003 Mar; 111(5):749-58. PubMed ID: 12618529
[TBL] [Abstract][Full Text] [Related]
16. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin.
Yang Q; McHugh KP; Patntirapong S; Gu X; Wunderlich L; Hauschka PV
Matrix Biol; 2008 Sep; 27(7):589-99. PubMed ID: 18640270
[TBL] [Abstract][Full Text] [Related]
17. Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat.
Crippes BA; Engleman VW; Settle SL; Delarco J; Ornberg RL; Helfrich MH; Horton MA; Nickols GA
Endocrinology; 1996 Mar; 137(3):918-24. PubMed ID: 8603604
[TBL] [Abstract][Full Text] [Related]
18. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
19. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption.
Schmidt S; Nakchbandi I; Ruppert R; Kawelke N; Hess MW; Pfaller K; Jurdic P; Fässler R; Moser M
J Cell Biol; 2011 Mar; 192(5):883-97. PubMed ID: 21357746
[TBL] [Abstract][Full Text] [Related]
20. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway.
Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY
J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
